Literature DB >> 2647043

Effects of ethamsylate on cerebral blood flow velocity in premature babies.

J M Rennie1, P K Lam.   

Abstract

Cerebral blood flow velocity and cardiac output were measured with ultrasound before and 30 minutes after the administration of ethamsylate in a double blind placebo controlled study of 19 very low birthweight infants. No differences were found before or after treatment in either group.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2647043      PMCID： PMC1590063          DOI： 10.1136/adc.64.1_spec_no.46

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  5 in total

1.  Ethamsylate reduces immunoreactive prostacyclin metabolite in low birthweight infants with respiratory distress syndrome.

Authors:  J M Rennie; J Doyle; R W Cooke
Journal:  Early Hum Dev       Date:  1986-12       Impact factor: 2.079

2.  Early administration of indomethacin to preterm infants.

Authors:  J M Rennie; J Doyle; R W Cooke
Journal:  Arch Dis Child       Date:  1986-03       Impact factor: 3.791

3.  Etamsylate as inhibitor of prostaglandin biosynthesis in pregnant human myometrium in vitro.

Authors:  L Kovács; G Falkay
Journal:  Experientia       Date:  1981-11-15

4.  The effect of indomethacin on cerebral blood-flow velocity in premature infants.

Authors:  D H Evans; M I Levene; L N Archer
Journal:  Dev Med Child Neurol       Date:  1987-12       Impact factor: 5.449

5.  Multicentre trial of ethamsylate for prevention of periventricular haemorrhage in very low birthweight infants.

Authors:  J W Benson; M R Drayton; C Hayward; J F Murphy; J P Osborne; J M Rennie; J F Schulte; B D Speidel; R W Cooke
Journal:  Lancet       Date:  1986-12-06       Impact factor: 79.321
  5 in total
  4 in total

1.  Etamsylate for prevention of periventricular haemorrhage.

Authors:  R W Hunt
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-01       Impact factor: 5.747

2.  The EC randomised controlled trial of prophylactic ethamsylate for very preterm neonates: early mortality and morbidity. The EC Ethamsylate Trial Group.

Authors: 
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-05       Impact factor: 5.747

Review 3.  Benefits and risks of pharmacological agents used for the treatment of menorrhagia.

Authors:  Samendra Nath Roy; Siladitya Bhattacharya
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

4.  Beneficial effects of early hemostasis on spinal cord injury in the rat.

Authors:  H Fan; K Chen; L Duan; Y-Z Wang; G Ju
Journal:  Spinal Cord       Date:  2016-05-03       Impact factor: 2.772
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.